Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Cancer Discovery
|
August 5, 2022
BCL10 Mutants: Architects of Oncogenic Signaling Provide a Blueprint for Precision Medicine
James D Phelan, Thomas Oellerich
Blood
|
March 18, 2021
Sorting biologic subtypes of primary CNS lymphoma
Mark Roschewski, James D Phelan
Blood
|
August 10, 2023
An AID to follicular lymphoma transformation
James D Phelan, Elaine S Jaffe
Nature
|
July 26, 2023
Double-headed molecule activates cell-death pathways in cancer cells
James D Phelan, Louis M Staudt
Current Opinion in Rheumatology
|
August 10, 2006
Genomic progress in pediatric arthritis: recent work and future goals
James D Phelan, Susan D Thompson
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2020
CRISPR-based technology to silence the expression of IncRNAs
James D Phelan, Louis M Staudt
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2024
Genotype from Phenotype: Using CRISPR Screens to Dissect Lymphoma Biology
Arnold Bolomsky, Jaewoo Choi, James D Phelan
Blood
|
April 18, 2024
Primary large B-cell lymphomas of immune-privileged sites
Mark Roschewski, James D Phelan, Elaine S Jaffe
Methods in Molecular Biology (Clifton, N.J.)
|
February 20, 2019
Protocols for CRISPR-Cas9 Screening in Lymphoma Cell Lines
Daniel E Webster, Sandrine Roulland, James D Phelan
Cancer Journal (Sudbury, Mass.)
|
June 5, 2020
Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma
Mark Roschewski, James D Phelan, Wyndham H Wilson
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Cancer Discovery
|
August 5, 2022
BCL10 Mutants: Architects of Oncogenic Signaling Provide a Blueprint for Precision Medicine
James D Phelan, Thomas Oellerich
Blood
|
March 18, 2021
Sorting biologic subtypes of primary CNS lymphoma
Mark Roschewski, James D Phelan
Blood
|
August 10, 2023
An AID to follicular lymphoma transformation
James D Phelan, Elaine S Jaffe
Nature
|
July 26, 2023
Double-headed molecule activates cell-death pathways in cancer cells
James D Phelan, Louis M Staudt
Current Opinion in Rheumatology
|
August 10, 2006
Genomic progress in pediatric arthritis: recent work and future goals
James D Phelan, Susan D Thompson
Proceedings of the National Academy of Sciences of the United States of America
|
April 5, 2020
CRISPR-based technology to silence the expression of IncRNAs
James D Phelan, Louis M Staudt
Methods in Molecular Biology (Clifton, N.J.)
|
October 18, 2024
Genotype from Phenotype: Using CRISPR Screens to Dissect Lymphoma Biology
Arnold Bolomsky, Jaewoo Choi, James D Phelan
Blood
|
April 18, 2024
Primary large B-cell lymphomas of immune-privileged sites
Mark Roschewski, James D Phelan, Elaine S Jaffe
Methods in Molecular Biology (Clifton, N.J.)
|
February 20, 2019
Protocols for CRISPR-Cas9 Screening in Lymphoma Cell Lines
Daniel E Webster, Sandrine Roulland, James D Phelan
Cancer Journal (Sudbury, Mass.)
|
June 5, 2020
Molecular Classification and Treatment of Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma
Mark Roschewski, James D Phelan, Wyndham H Wilson
Page
of 5